Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

TransMedics Group, Inc. (TMDX)

Hernandez Gerardo — Chief Financial Officer
Mar 4, 2026
Sale
Shares
5,912
Price
$147.21
Total Value
$870.31K
Shares Held After
14,689
% of Holdings
28.7%

TransMedics Group, Inc. (TMDX)

Hernandez Gerardo — Chief Financial Officer
Mar 4, 2026
Sale
Shares
1,324
Price
$147.21
Total Value
$194.91K
Shares Held After
14,689
% of Holdings
8.3%
Shares
19,715,000
Price
$40.96
Total Value
$807.55M
Shares Held After
42,227,032
% of Holdings
31.8%
Shares
19,715,000
Price
$40.96
Total Value
$807.55M
Shares Held After
42,227,032
% of Holdings
31.8%

ARTIVION, INC. (AORT)

Holloway Jean F — SVP, General Counsel
Mar 4, 2026
Sale
Shares
8,962
Price
$38.00
Total Value
$340.56K
Shares Held After
185,095
% of Holdings
4.6%
Mar 4, 2026
Purchase
Shares
30,000
Price
$1.87
Total Value
$56.10K
Shares Held After
6,352,611
% of Holdings
0.5%
Mar 4, 2026
Sale
Shares
2,671
Price
$70.94
Total Value
$189.49K
Shares Held After
767,780
% of Holdings
0.3%
Mar 4, 2026
Sale
Shares
7,329
Price
$69.94
Total Value
$512.62K
Shares Held After
770,451
% of Holdings
0.9%

Kymera Therapeutics, Inc. (KYMR)

Gollob Jared — Chief Medical Officer
Mar 4, 2026
Sale
Shares
447
Price
$86.62
Total Value
$38.72K
Shares Held After
117,134
% of Holdings
0.4%

Kymera Therapeutics, Inc. (KYMR)

Gollob Jared — Chief Medical Officer
Mar 4, 2026
Sale
Shares
1,437
Price
$85.78
Total Value
$123.27K
Shares Held After
117,581
% of Holdings
1.2%

Kymera Therapeutics, Inc. (KYMR)

Gollob Jared — Chief Medical Officer
Mar 4, 2026
Sale
Shares
2,519
Price
$85.04
Total Value
$214.21K
Shares Held After
119,018
% of Holdings
2.1%

Kymera Therapeutics, Inc. (KYMR)

Gollob Jared — Chief Medical Officer
Mar 4, 2026
Sale
Shares
492
Price
$84.00
Total Value
$41.33K
Shares Held After
121,537
% of Holdings
0.4%

Kymera Therapeutics, Inc. (KYMR)

Chadwick Jeremy G — Chief Operating Officer
Mar 4, 2026
Sale
Shares
358
Price
$86.62
Total Value
$31.01K
Shares Held After
73,810
% of Holdings
0.5%

Kymera Therapeutics, Inc. (KYMR)

Chadwick Jeremy G — Chief Operating Officer
Mar 4, 2026
Sale
Shares
1,150
Price
$85.78
Total Value
$98.65K
Shares Held After
74,168
% of Holdings
1.5%

Kymera Therapeutics, Inc. (KYMR)

Chadwick Jeremy G — Chief Operating Officer
Mar 4, 2026
Sale
Shares
2,017
Price
$85.04
Total Value
$171.52K
Shares Held After
75,318
% of Holdings
2.6%

Kymera Therapeutics, Inc. (KYMR)

Chadwick Jeremy G — Chief Operating Officer
Mar 4, 2026
Sale
Shares
394
Price
$84.00
Total Value
$33.09K
Shares Held After
77,335
% of Holdings
0.5%

Kymera Therapeutics, Inc. (KYMR)

Jacobs Bruce N. — Chief Financial Officer
Mar 4, 2026
Sale
Shares
447
Price
$86.62
Total Value
$38.72K
Shares Held After
232,588
% of Holdings
0.2%

Kymera Therapeutics, Inc. (KYMR)

Jacobs Bruce N. — Chief Financial Officer
Mar 4, 2026
Sale
Shares
1,437
Price
$85.78
Total Value
$123.27K
Shares Held After
233,035
% of Holdings
0.6%

Kymera Therapeutics, Inc. (KYMR)

Jacobs Bruce N. — Chief Financial Officer
Mar 4, 2026
Sale
Shares
2,519
Price
$85.04
Total Value
$214.21K
Shares Held After
234,472
% of Holdings
1.1%

Kymera Therapeutics, Inc. (KYMR)

Jacobs Bruce N. — Chief Financial Officer
Mar 4, 2026
Sale
Shares
492
Price
$84.00
Total Value
$41.33K
Shares Held After
236,991
% of Holdings
0.2%
Mar 3, 2026
Sale
Shares
6,000
Price
$74.23
Total Value
$445.38K
Shares Held After
52,405
% of Holdings
10.3%
Mar 3, 2026
Purchase
Shares
184,208
Price
$14.22
Total Value
$2.62M
Shares Held After
12,229,500
% of Holdings
1.5%
Mar 3, 2026
Purchase
Shares
22,445
Price
$14.03
Total Value
$314.86K
Shares Held After
50,000
% of Holdings
44.9%
Mar 3, 2026
Sale
Shares
2,380
Price
$16.15
Total Value
$38.44K
Shares Held After
1,934,247
% of Holdings
0.1%
Mar 3, 2026
Sale
Shares
50,703
Price
$15.49
Total Value
$785.39K
Shares Held After
1,936,627
% of Holdings
2.6%
Mar 3, 2026
Purchase
Shares
5,000
Price
$13.47
Total Value
$67.34K
Shares Held After
5,000
% of Holdings
100.0%

Teladoc Health, Inc. (TDOC)

Rodrigues Fernando M. — President of BetterHelp
Mar 3, 2026
Sale
Shares
25,086
Price
$4.98
Total Value
$124.98K
Shares Held After
0
% of Holdings
100.0%

Alector, Inc. (ALEC)

Wong-Sarad Grace — Principal Accounting Officer
Mar 3, 2026
Sale
Shares
3,367
Price
$2.08
Total Value
$7.01K
Shares Held After
107,465
% of Holdings
3.0%
Mar 3, 2026
Sale
Shares
50
Price
$509.20
Total Value
$25.46K
Shares Held After
170
% of Holdings
22.7%

Bausch Health Companies Inc. (BHC)

Carson Seana — EVP, General Counsel
Mar 3, 2026
Sale
Shares
4,420
Price
$5.77
Total Value
$25.50K
Shares Held After
616,761
% of Holdings
0.7%

ARTIVION, INC. (AORT)

Berry Lance A — EVP, COO, CFO & Treasurer
Mar 3, 2026
Sale
Shares
6,316
Price
$37.78
Total Value
$238.59K
Shares Held After
210,827
% of Holdings
2.9%

QUEST DIAGNOSTICS INC (DGX)

PREVOZNIK MICHAEL E — SVP & General Counsel
Mar 3, 2026
Sale
Shares
526
Price
$207.73
Total Value
$109.27K
Shares Held After
37,557
% of Holdings
1.4%
Mar 3, 2026
Purchase
Shares
1,000
Price
$21.89
Total Value
$21.89K
Shares Held After
8,397
% of Holdings
11.9%
Mar 3, 2026
Purchase
Shares
25
Price
$174.54
Total Value
$4.36K
Shares Held After
27,448
% of Holdings
0.1%

ARTIVION, INC. (AORT)

Davis John E — Chief Commercial Officer
Mar 3, 2026
Sale
Shares
4,573
Price
$37.78
Total Value
$172.75K
Shares Held After
230,794
% of Holdings
1.9%

Crinetics Pharmaceuticals, Inc. (CRNX)

Schilke Tobin — Chief Financial Officer
Mar 3, 2026
Sale
Shares
6,713
Price
$39.67
Total Value
$266.30K
Shares Held After
78,121
% of Holdings
7.9%
Mar 3, 2026
Sale
Shares
161,275
Price
$3.71
Total Value
$598.65K
Shares Held After
8,513,048
% of Holdings
1.9%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Mar 3, 2026
Sale
Shares
632
Price
$207.73
Total Value
$131.29K
Shares Held After
67,122
% of Holdings
0.9%

Butterfly Network, Inc. (BFLY)

Cashman Steve — Chief Business Officer
Mar 3, 2026
Sale
Shares
42,540
Price
$3.71
Total Value
$157.91K
Shares Held After
2,377,386
% of Holdings
1.8%
Mar 3, 2026
Sale
Shares
170,000
Price
$3.46
Total Value
$588.20K
Shares Held After
6,259,863
% of Holdings
2.6%

QUEST DIAGNOSTICS INC (DGX)

Plewman Patrick — SVP for Diagnostic Services
Mar 3, 2026
Sale
Shares
410
Price
$207.73
Total Value
$85.17K
Shares Held After
15,198
% of Holdings
2.6%

Butterfly Network, Inc. (BFLY)

Carlson Megan — CAO and SVP, Finance
Mar 3, 2026
Sale
Shares
41,978
Price
$3.71
Total Value
$155.82K
Shares Held After
617,631
% of Holdings
6.4%
Mar 3, 2026
Sale
Shares
3,000
Price
$39.67
Total Value
$119.01K
Shares Held After
13,300
% of Holdings
18.4%
Mar 3, 2026
Purchase
Shares
18,200
Price
$0.41
Total Value
$7.37K
Shares Held After
5,942,275
% of Holdings
0.3%

CASTLE BIOSCIENCES INC (CSTL)

Stokes Frank — Chief Financial Officer
Mar 3, 2026
Sale
Shares
1,700
Price
$27.81
Total Value
$47.28K
Shares Held After
52,483
% of Holdings
3.1%

CASTLE BIOSCIENCES INC (CSTL)

Stokes Frank — Chief Financial Officer
Mar 3, 2026
Sale
Shares
5,300
Price
$27.32
Total Value
$144.80K
Shares Held After
54,183
% of Holdings
8.9%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Daniell Richard — EVP, Europe Commercial
Mar 3, 2026
Sale
Shares
66,735
Price
$32.36
Total Value
$2.16M
Shares Held After
123,127
% of Holdings
35.1%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Daniell Richard — EVP, Europe Commercial
Mar 3, 2026
Sale
Shares
62,250
Price
$32.36
Total Value
$2.01M
Shares Held After
48,384
% of Holdings
56.3%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Savage Brian — Interim Chief Legal Officer
Mar 3, 2026
Sale
Shares
1,274
Price
$32.36
Total Value
$41.23K
Shares Held After
2,926
% of Holdings
30.3%
Mar 3, 2026
Sale
Shares
120
Price
$509.62
Total Value
$61.15K
Shares Held After
123,925
% of Holdings
0.1%
Version: v26.3.31